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Abstract
Introduction: Female sex workers (FSWs) are at high-risk for HIV acquisition in South Africa, where the advent of new HIV
prevention and treatment interventions represent the potential to significantly impact the epidemic. This paper focuses on
aspects of PrEP acceptability as a new intervention within the context of a larger service delivery programme including the
simultaneous rollout of early ART. This paper explores PrEP acceptability among the FGD participants as future potential
users.
Methods: FGDs were conducted in two clinic-based sites in Johannesburg and Pretoria. They aimed to explore community-
level, multi-dimensional acceptability of PrEP within the context of imminent implementation alongside early ART in the TAPS
Demonstration Project. Sex worker peer educators recruited participants from varying sex work locales. Facilitation was in
English with adaptation by facilitators into local languages as needed. Transcripts were translated and transcribed into English.
Thematic analysis was used to analyse the data.
Results: Four FGDs were conducted in each site for a total of eight FDGs and 69 participants. Demographics were largely
similar across the sites. Overall, there was strong acceptability of PrEP among participants and positive anticipation for the
imminent delivery of PrEP in the local sex worker clinics. Themes arising from the discussions exploring aspects of PrEP
acceptability included: awareness and understanding of PrEP; PrEP motivations including choice, control, and vulnerability,
managing PrEP risks and worries; and, de-stigmatizing and empowering PrEP delivery. Participant discussions and recommen-
dations highlighted the importance of developing clear education and messaging to accurately convey the concept of PrEP, and
intervention integration into supportive and tailored services.
Conclusions: Through the course of these FGDs, PrEP became a positive and highly anticipated prevention option among the
FSWs participants who endorsed implementation in their communities. Effective integration of PrEP into existing services will
include comprehensive health programming where ART is also available, appropriate messaging, and support.
Keywords: HIV prevention; biomedical prevention products; pre-exposure prophylaxis (PrEP); sex work; qualitative research
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1 | INTRODUCTION
Female sex workers (FSWs) are at high-risk for HIV acquisi-
tion in South Africa, with a recent study reporting a preva-
lence of 72% in the greater Johannesburg area, and 40% and
54% in Cape Town and Durban respectively [1]. The advent
through clinical trials of oral pre-exposure prophylaxis (PrEP)
for HIV prevention [2], and test and treat (also “early ART”)
for HIV treatment [3,4], represent the potential to significantly
impact the epidemic. As a result, these two interventions have
become part of the standard of care set out by the World
Health Organization (WHO) in 2015 [5].
Both PrEP and early ART require consistent use (adher-
ence) to their respective regimens to successfully prevent HIV
acquisition or transmission. PrEP trials including only women
struggled with maintaining adherence levels required to
confer protection [6-8]. As countries move towards implemen-
tation and scale-up and in the light of ensuring proper pro-
gramming is in place to support proper, consistent use,
formative research on the feasibility and acceptability of inte-
grating PrEP (and test and treat) into local and national pro-
grammes is progressing, in particular for target populations
[9]. However, little has yet been published in low and middle-
income country settings about community perspectives on the
acceptability these interventions in a context where they are
soon to be implemented. The acceptability of, and willingness
to engage with, an intervention is central to its development,
rollout and scale-up, and understanding how it is may be per-
ceived by target populations can help counter or mitigate
unintended consequences or potential barriers [10,11].
Dimensions of acceptability contributing to successful uptake
and use can include personal preferences around ease of use
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and product attributes (including actual and perceived efficacy);
social factors including stigma from partners, family, and friends,
and social norms; interactions with medical facilities and service
delivery mechanisms; the policy and regulatory landscape; and
the context of the HIV epidemic itself [12,13]. The relative value
of these dimensions is often mediated by interactions with the
other dimensions as well as an individual’s perception of HIV
risk [13]. Some of these elements were explored in previous
PrEP and vaginal microbicide efficacy trials, though they more
often focused on product attributes [14]. Following these quali-
tative findings, however, a holistic, multi-dimensional approach
to acceptability was considered to be critical to promote effec-
tive use during scale-up [15].
There is limited previously published qualitative research
regarding PrEP acceptability specifically among FSWs in sub-
Saharan Africa. Most microbicide trials targeted women at
high risk, which included but did not focus on sex workers
[16-20], apart from some of the nonoxynol-9 vaginal gel stud-
ies [21,22]. One study on intermittent PrEP in Kenya included
men who have sex with men (MSM) and FSWs [23], however,
only five FSWs were included and results were not disaggre-
gated. Lenses into PrEP acceptability among sex workers have
been made available through research with people who use
drugs, such as one Canadian study which found that engaging
in sex work was in itself a motivation to take up PrEP [24].
While limited in scope, findings from these studies, have
pointed to values and perspectives around PrEP particular to
FSWs’ work and roles as women.
Given that the transition to PrEP implementation is recent,
the multiple dimensions of acceptability are yet to be fully
understood as drug-based prevention is unfamiliar to the
wider public. In addition, service providers’ experience with
rolling out ART programmes, and the delivery of contraception
to prevent unwanted pregnancies, could provide a basis for
understanding PrEP where services would be similar, but
motivations to take the medication would differ in prevention
versus treatment.
In this paper, we present findings from focus group discus-
sions (FGDs) that sought to inform the design of oral PrEP and
(then called) early ART interventions for FSWs in Johannes-
burg and Pretoria for implementation in the Treatment And
Prevention for Sex workers (TAPS) Demonstration Project
[25]. The findings presented here focus solely on dimensions of
PrEP acceptability, where at the time of data collection, the
role and potential of PrEP had not yet been normalized by
government guidelines and national regulatory approval. This
paper considers PrEP as a new intervention within the context
of impending provisions within a larger service delivery pro-
gramme including the simultaneous rollout of early ART. The
aim of this paper is to specifically explore PrEP acceptability
among the FGD participants as future potential users.
2 | METHODS
FGDs were conducted in two clinic-based settings in Johan-
nesburg and Pretoria between July and December 2014. The
two clinics were part of the larger Wits RHI Sex Worker Pro-
gramme which provides comprehensive primary care services
to female, male and transgender sex workers in a variety of
settings. These services include: HIV counselling and testing
and condom distribution, NIMART (nurse-initiated and man-
aged antiretroviral treatment), tuberculosis screening, HPV
screening, clinical services for minor ailments, psychosocial
support, and referrals to both clinical and legal services. The
clinics, services and programme are described in further detail
in several other publications, including a detailed account of
the formative research conducted during the design of the
TAPS project [25-29].
They aimed to explore community-level acceptability of a
PrEP (and early ART) intervention with a view to learn how
this could influence uptake and use in TAPS. A holistic, multi-
dimensional approach to acceptability was employed, including
perspectives from both HIV-negative and HIV-positive women
on both interventions.
Initial topics for discussion were developed based on the
results of an adapted meta-ethnography of women’s experi-
ences of uptake and use of biomedical HIV prevention prod-
ucts across sub-Saharan Africa [30,31], as well as the
Modified Social Ecological Model (MSEM) designed by Baral
et al. [32]. Discussions encouraged community-level narratives
of women’s lives and experiences with their work and health
services; perceptions of optimal prevention and treatment
delivery; knowledge, attitudes, and perceptions of health and
wellbeing, and of PrEP and early ART specifically; acceptability
of and commitment to increased, frequent clinical monitoring
and HIV testing; and identifying overall motivations and barri-
ers to accessing services, and in particular, PrEP as the newest
intervention.
Sex worker peer educators recruited women through their
work/social networks from varying sex work locales (brothels,
streets and other informal areas) aiming to gather diverse
perspectives from different working and living environments.
Only cis gendered women were recruited as the eventual
demonstration project did not include any other populations.
Discussions were facilitated primarily in English with adapta-
tion by facilitators and staff note takers into local languages
as needed. An introduction was provided at the beginning of
each FGD session to orient participants as to the purpose of
the discussions and the topics to be discussed. This is included
in Annex 1. Background information on PrEP (and early ART)
was provided within the context of each group dynamic and
as the topic arose, which varied depending on participant’s
knowledge. FGDs lasted between one and a half and two
hours. Participants in the FGDs were given R50 (~4 USD) to
reimburse for travel costs and refreshments in the form of
juice and sandwiches following each FGD session. No other
compensation was given for this research.
2.1 | Analysis
Transcripts for each of the FGDs were translated and tran-
scribed into English, then uploaded into NVIVO (version 10.0,
Burlington MA). Analysis followed principles of Braun and
Clarke’s thematic analysis [33] beginning with a set of ques-
tions building from themes derived from the discussion guide
based on the MSEM but we remained open to new lines of
enquiry as they emerged from the data in an inductive man-
ner. The coding framework was devised by the primary author
with support from two other researchers, and all transcripts
were coded in duplicate by two researchers. Inter-coder relia-
bility was not a focus of the analysis, rather coding choices
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were discussed throughout and at the end of the coding pro-
cess to resolve any differences.
2.2 | Ethical considerations
All participants provided their informed consent and pseudo-
nyms to protect identities, indicated in this paper as colours.
This study was reviewed and approved by the Wits Human
Research Ethics Committee (reference number: M131009).
3 | RESULTS
3.1 | Participant demographics
Four FGDs were conducted in each site for a total of eight
FDGs and 69 participants. Key demographic characteristics
are displayed in Table 1.
Participants were not asked to disclose their HIV status,
however most participants did so of their own volition during
the discussions. From their disclosures we estimate about
50% to 75% of the participants were HIV-positive, which is
similar to the estimated prevalence in the greater
Johannesburg area [1], and to what was observed in Pretoria
during outreach and HIV testing during formative work.
While there was relative diversity among the FGD partici-
pants, themes arising from the discussions did not differ
across the groups. To qualitatively assess overall aspects of
PrEP acceptability, we review the thematic findings here in
terms of: awareness and understanding of PrEP; PrEP motiva-
tions including choice, control, and vulnerability, managing
PrEP risks and worries; and, de-stigmatizing and empowering
PrEP delivery. Quotes from participants are labelled with their
chosen colour pseudonyms, abbreviation of site location
(JHB=Johannesburg; PTA= Pretoria), and FGD number.
3.2 | Awareness and understanding of PrEP
Prior awareness of PrEP was explored within the context of
existing or known HIV prevention options. Most of the discus-
sion centred on male and female condoms, however some
women acknowledged male circumcision and prevention of
mother to child transmission (PMTCT), and some had heard
of, or participated in, studies involving the vaginal gel and ring.
Apart from condoms, post-exposure prophylaxis (PEP) was
most often discussed, along with STI treatments and/or the
morning after pill for unwanted pregnancies. “If you do sleep
with a client and a condom gets broken . . .. everybody decides
to drink that pill. But it’s just for cleaning, we know it doesn’t
prevent HIV” (Brown, PTA 3). Considering PrEP within the
context of other previously known options, or lack thereof,
allowed women to recognize and interpret PrEP as a potential
choice for prevention.
Prior to a detailed description of PrEP within the FGDs,
awareness was low. Initial understanding of PrEP was usually
reached by equating it with contraception. “Okay meaning that
people who are going to take this tablet they must be very
careful because a pill for preventing, it’s very risky, because
once you forget . . .. like on birth control pills, it’s very risky
. . ..” (Red, PTA 4). Alternatively, the concept of PrEP was fur-
ther assimilated through prior knowledge and experience with
HIV testing and ART.
Questions relating to awareness and understanding of PrEP
frequently resulted in discussions about what type of woman
could and should use PrEP, or who would make a “good PrEP
taker.” There was universal understanding of motivations to
take PrEP for HIV-negative women, however it was the need
for a certain degree of commitment which the participants
focused on:
She has to take care for herself . . .., so she must behave like
a person who prevents when she is avoiding to fall preg-
nant. But she shouldn’t be like when someone prevents and
they skip a pill and they would say “aggh even if I forgot to
take my pill nothing will happen to me.” So with PrEP she
must continue using it every day (Green, PTA 4).
3.3 | PrEP motivations: choice, control and
vulnerability
An awareness of the high prevalence of HIV among FSWs in
their communities underscored the need for more prevention
options to safeguard those who were still HIV-negative. “The
methods are very limited. . . .. The only method that we know





n = 30 Total
Age
20 to 29 8 15 23
30 to 44 26 12 38
45+ 5 3 8
Relationship status
Single 35 24 59
Married or steady partner 1 2 3
Divorced or separated 2 2 4
Widowed 1 2 3
Education
No School 0 2 2
Primary 3 1 4
Grade 8 to 12 35 25 60
Higher 1 2 3
Place of Birtha
Gauteng 7 13 20
Other SA Provinces 22 6 28
Other Countries 10 10 20
Place of Residence (by area)
Hillbrow 20 20
Greater Johannesburg 19 3 22
Pretoria CBD 15 15
Greater Pretoria 10 10
Brits (Northwest Province) 2 2
Other SA provinces, Free State, Eastern Cape, KwaZulu-Natal, Lim-
popo, Mpumalanga; Other Countries, Zimbabwe, Mozambique,
Lesotho; Greater Johannesburg, Central Business District (CBD),
Soweto, Yeoville, Berea, Ekurhuleni; Greater Pretoria, Soshanguve,
Mamelodi, Atteridgeville.
a1 participant did not list place of birth in Pretoria.
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so far is to use a condom, and. . .. it can burst anytime”
(Brown, JHB 1).
These sentiments laid the groundwork for seemingly univer-
sal approval and anticipation of PrEP, which FGD facilitators
indicated would be imminently offered in the clinics in their
locality:
People are dying outside of HIV. And HIV is spreading so
fast . . .. At least people who are still negative will have a
chance to stay negative. . .. So the spreading of HIV will get
limited. Then as time goes by the HIV rate will go down . . ..
I don’t want my daughter to go through what I am going
through now. (Brown, JHB 1).
All of the women immediately saw the benefit of having
PrEP in the body, especially given that condoms often burst
or were removed. “PrEP is good because it stays in your
blood” (Red, PTA 3). As sex workers, participants reported
how they frequently found themselves in vulnerable positions
with clients, which could be hard to anticipate or plan for. In
such circumstances, PrEP could be invaluable in protecting
women from HIV where they would have personal control
over one method of protection. “Even with a client in your
own house, they can throw away the condom, strangle you
and leave you helpless because you do not want to use a
condom. And do as they please with you” (Purple, JHB1).
Experiences of sexual violence were frequently reported
(unprompted) within groups, and were seen as particularly
motivating for PrEP uptake and use. “Another thing, as a sex
worker, there is no one here who say they not been gilwa
(treated badly). Maybe they even, some of us we have even
been ganged raped. So I believe we have to test continuously,
time and again” (Brown, JHB 1).
Finally, in their own recognition that the primary HIV risk
for FSWs came from their main partners rather than clients,
many participants reflected on the utility of PrEP in protecting
them in the likely event that their partner was also having sex
with other women:
Even if she says, that boyfriend, she loves him, there are
many hotels. He doesn’t have her only. The other hotels
there are many he’s got another girlfriend, the other hotel,
he’s got another. And he’s been sleeping with them without
that condom (Red, JHB1).
While at the time of the FGDs many of the women did not
report having a current main partner, most of the women
recounted experiences with previous main partners which
they felt primarily contributed to their risk (and often led to
the end of those partnerships). Such sentiment informed a
belief expressed by many that PrEP should be made available
to all women, rather than just FSWs. “Yes I also agree with
them that the entire woman should use PrEP who are HIV-
negative because again they also don’t know who their hus-
bands are sleeping with” (Brown, PTA, 4).
3.4 | Managing PrEP risks and worries
While the potential to reduce HIV transmission was keenly
recognized and appreciated, women were also acutely aware
of a range of other risks in their sexual, social and personal
environments that might influence their willingness to use
PrEP. These would, they felt, require careful consideration and
management.
A primary concern related to the potential discontinuation
of condom use in the context of PrEP, and the implications of
this for acquisition of other sexually transmitted infections
(STIs) or unwanted pregnancies:
But what I think, neh, if they are going to use these PrEP
pills they have to teach people well, that they must use
condoms. Make them to be aware of what is going to hap-
pen because of, if they say ok you can keep on drinking
these pills they will start forgetting to use condoms and
start to sleep around without. That’s why they’re scared,
that many teenagers of South Africa, they will have plenty
of babies (Red, JHB 1).
All of the women agreed that PrEP could not take the place
of condoms, and that the two should go together in order to
prevent other STIs and unwanted pregnancies, especially since
most of the women acknowledged not using other modes of
contraception. This perception reflected a general sense that
PrEP would serve as useful backup when condoms failed,
rather than being seen as the primary prevention strategy.
The risk of potential non-adherence, and thus diminished
PrEP effectiveness, was commonly expressed. Many partici-
pants felt that some women may not be sufficiently motivated
to take a pill every day, especially when they were not feeling
unwell. This experience was reflected by some in the group
who disclosed their HIV-positive status:
It’s difficult to support somebody who’s not sick and say
she must take medication especially every day. At the clinic
they will always check and tell you that your viral load is
high, but you will tell yourself that there is no need to take
that medication, rather take drugs and you will be ok
(Brown, PTA 3).
Additional worries around adherence included substance
use (alcohol and illicit drugs) and the potential for forgetting
to take a daily pill. “. . .. those who are using drugs, they
won’t be able to take PrEP every day because they will for-
get under the influence of drugs” (Brown, PTA, 3). However,
there was also discussion about how lessons learned in ART
adherence among HIV-positive women could help improve
adherence among those taking PrEP, such as aligning pill tak-
ing with television shows, using phone alarms, and coming up
with strategies to keep pills on hand such as in secret bra
compartments.
Importantly, the discussion of substance use raised ques-
tions about whether PrEP could be taken even when someone
knew they would be drinking or using other substances during
the course of the day. “So this PrEP it’s not for HIV-positive,
so I want to ask something, is there somewhere where it says
don’t smoke, don’t drink . . ..?” (Grey, PTA 4). Explaining
that using alcohol or other drugs would not diminish the
preventive effects of PrEP was met with approval from the
participants.
The perception of potential side effects, especially given
knowledge of ART side effects from existing drugs on the mar-
ket, was seen as a likely major barrier to uptake:
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Yes, maybe they will come for counselling first before they
take the PrEP right, and then they tell them about the side
effects and then a person gets scared of it and say, my
goodness no, you know what these side effects are going to
do to me, “they will make me sick, they will make me throw
up, I will die” you see that kind of thing, or you will be pain-
ing (Red, JHB 4).
Interestingly, as a result, participants felt it would be impor-
tant to ensure clear messaging around potential side effects
and their duration was central to in the promotion of PrEP.
Perhaps less common were concerns that focused more on
logistical and social aspects outside of the women’s control,
such as the pills being stolen outside clinics:
They know that this one has come to fetch her pills, they
steal them from you, you get hurt. They know that they are
going to use the pills as drugs. You know that you will be
mugged, they hold you up they stab you, what do you do?
You are now not killed because of your AIDS but for your
pills (Purple, JHB 1).
3.5 | De-stigmatizing and empowering PrEP
delivery
The need for supportive, non-judgmental services tailored to
sex workers was universally stated. “It is right that such a
clinic is there. . . .. having such a clinic will make people not
shy to go to the clinic. They can speak freely, because the
clinic is ours” (Black, JHB 4). Indeed, positive interactions in
the clinic would motivate women to return: “. . ..when a clinic
treats you well, you return to it, but if they don’t treat you
properly you don’t return” (Red, JHB 2). Including PrEP as
part of this type of service delivery environment was consid-
ered paramount to successful implementation.
In addition, having PrEP offered alongside early ART was
considered important in destigmatizing interventions. Given
the high HIV prevalence rate, of which women were keenly
aware, there was a sense of chronic distress concerning the
inevitability of becoming HIV-positive among the larger FSW
population, and certainly among the FGD participants. There-
fore, many of the women felt that PrEP presented an oppor-
tunity to “de-stress”, or remove some of that panic and the
dread of HIV infection. In addition, the HIV-positive women
felt that having additional protection in the community might
result in fewer infections.
The need for social support, often initially voiced by women
with ART experiences, was identified universally as a valued
component of pill-taking and a way to help ensure commit-
ment:
If you get somebody who supports you in what you are doing
it’s much more easier for you to continue than when they
don’t have anybody next to you. Like a person like my sister
is my biggest supporter. Immediately when I found out I am
positive that’s the first person I told. (Purple, JHB 1).
Finally, flexibility in service delivery was underscored as
critical for a successful PrEP intervention. This stemmed
from not having much time to go to the clinic due to having
to work long hours to pay rent, as well as having become
habituated to mobile services in the case of the Johannes-
burg groups:
I don’t pay rent. I do business to feed myself. The other’s on
the streets they are staying in flats.. . . they need [money]
for rent that’s why they work the whole night. So we are
different in that, you who is staying in a hotel, you don’t
have time to come to clinic, you are waiting for a mobile
clinic to come, you understand? (Green, JHB 1).
4 | DISCUSSION
Our findings indicate strong acceptability of PrEP among
FSWs in the two communities and positive anticipation for the
imminent delivery of PrEP in the local sex worker clinics.
Indeed, women were so positive at the end of each session
that they independently asked to create waiting lists to be
informed as soon as the TAPS project was launched so they
could be the first to enrol. These FGD participants in turn
provided useful insights according to their concerns into how
uptake and use could be ensured by this most-at-risk popula-
tion in South Africa. These centred on developing clear educa-
tion and messaging to accurately convey the concept of PrEP
and the need to ensure continued condom use, as well as
intervention integration into supportive and tailored services.
Fitting PrEP within existing knowledge of ART and PEP,
while equating it with contraception as a prevention modality,
was an effective and naturally developed education strategy
among participants, which has also been true among research-
ers [34]. In addition, experiences with early ART or PEP can
translate to PrEP, such as taking medication every day even
while feeling well. Discussions in these FGDs suggested that
HIV-negative and positive women could provide valuable sup-
port systems, a strategy which was successfully used in
another study in Zimbabwe [35], and may prove useful for
normalizing and implementing the two interventions in scale-
up. Since the TAPS project was to be implemented in the lar-
gely peer-driven health services of the Wits RHI Sex Worker
Programme, the interest from HIV-positive women as well as
older sex workers generally, presented an opportunity to con-
sider additional support and normalization systems.
Discussions concerning condom use usually focused on the
reliability of condoms with clients (where clients could not be
trusted not to remove or damage condoms, or condoms them-
selves could not be trusted not to burst), and use with main
partners with whom condom use was seen as untrusting or
unloving. This translated into one of the key motivations for use
of having an additional layer of protection and personal control,
to safeguard against the unpredictable such as sexual violence
at work or lack of condom use with main partners with an
unknown HIV status. This notion of additional protection and
the relevant reasons are fairly different than what has been
articulated by MSM who have been more concerned with (lack
of) accurate risk perception and stigma within their social circles
[36], suggesting the need to carefully consider differences in
population perspectives when planning to rollout PrEP. Interest-
ingly, changes in condom use over time were primarily seen in
the efficacy and implementation studies with MSM, as opposed
to the studies with heterosexual men and women [2] which may
correlate with the different needs and desires of the populations.
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It should also be noted that many of the women in these
FGDs declared not currently using contraception other than
condoms. This is reflected in other studies conducted in the
same area [1,28]. This is largely due to the lack of availability
of options outside of the Depo-provera injection which was
known in the population to have side effects (cramps, exces-
sive bleeding, nausea) which negated the contraceptive bene-
fit, especially in the context of the work environment. While
this was not explored in detail in this particular research, the
reasons behind lack of contraception use were well-known in
the community and the larger health programme which was in
the process of implementing additional contraception options
at the time these FGDs were conducted. In addition, consider-
ing the implementation aspects of PrEP could also be an
opportunity to expand contraception options and improve ser-
vice delivery, as well for other relevant health needs such as
STIs.
Of particular note were the participants’ worries and con-
cerns in our study about the broader effects of PrEP and
potential for misuse and misinterpretation. Their recognition,
combined with the same awareness among other current and
existing users in other parts of the world [36-38], should
come as a reassurance to those with apprehensions that the
introduction of PrEP could be mismanaged leading to declines
in condom use [39]. Participants felt strongly that the addition
of PrEP should be seen as a back-up for when condoms failed
for the various reasons previously mentioned, but that PrEP
was an important new option that should be offered to all
HIV-negative women.
Finally, data from our study suggest that normalization may
be an important factor when considering PrEP rollout. There
was overall agreement that all women, and even men, should
have access to PrEP, and that PrEP should be combined with
early ART in the same clinic. The notion of stress around HIV
infection was a strong recurring theme, relating to individual
disease burden as well as stigma, where a strategy around
normalization of both PrEP and early ART could play an
important role. The articulation of the stress of HIV and
stigmatization of pill taking, points as well to the need to
include HIV-positive individuals in the discussion, to garner
their perspectives and longer-term commitment to pill taking.
The main limitation in this research is the snowball sampling
used to recruit participants which may have resulted in enrol-
ment of more informed or vocal women and/or women who
have been continuously involved in sex worker programme
outreach activities. However, this was less the case in Pretoria
where services had not previously existed, and these women
may have represented potential “early adopters” who could be
critical in promoting PrEP. There were also fewer women who
had a main partner at the time of the sessions than seen in
the larger local population [1,28]. In addition, the FGDs
included only FSWs and took place only in two urban areas,
which may limit generalizability to other populations and con-
texts. The theoretical nature of the FGDs, where actual use
was imminent but not yet in place, may not translate into sub-
sequent uptake of PrEP. Finally, the overwhelming positivity
towards PrEP (and early ART) as an outcome of the FGDs
was surprising. Negative sentiments were actively probed dur-
ing the sessions but were difficult to draw out. It is possible
that this reflects the group setting and a conformity bias,
though participants’ suggestions to start waiting lists for the
intervention launch was unprompted, indicating high and inde-
pendent positivity.
5 | CONCLUSION
Through the course of these FGDs, PrEP became a highly
anticipated prevention option among the FSWs participants
who positively endorsed its implementation in their communi-
ties. Participants shared important insights and interpretations
of acceptability for consideration in implementation, including
the imperative for nuanced messaging around condom use
and risk reduction. Integrating PrEP into existing services as
part of a comprehensive health programme, where ART is also
available, was seen as a best practice as long as attention is
paid to ensuring the appropriate messaging and support are
included.
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INTRODUCTION TO FOCUS GROUP
DISCUSSIONS FOR PARTICIPANTS
The following text was read at the start of each focus group
discussion session to orient participants as to the purpose of
the discussions and topics to be discussed.
We are holding a few discussions with up to 10 women at
a time to talk about experiences with health care in general
and more specifically HIV testing, prevention and care ser-
vices. These discussions will help us understand whether we
can put together a set of services tailored especially for
female sex workers that will support their needs. We would
like to find out what you think about current services, what
is missing from them, what kinds of services you wish were
available, difficulties in accessing testing and care, and your
thoughts about new potential services.
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